Intellectual Property

A California jury unanimously ruled in favor of ImprimisRx in a trademark infringement lawsuit filed against OSRX and its related party Ocular Science, according to a press release.

Conformis Inc. has entered into definitive agreements to sell and license certain assets relating to patient-specific instrumentation technology to Stryker Corporation, and to develop, manufacture and supply patient-specific instrumentation for use in connection with Stryker’s knee implant offerings.

A U.S. District Court judge has ruled in favor of Amgen in its lawsuit against Novartis’ Sandoz, which claimed patent infringement on its biologic etanercept by the biosimilar, etanercept-szzs.